# Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition

> **NCT04861649** · NA · UNKNOWN · sponsor: **Shanghai Asclepius Meditec Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Fecal Microbiota Transplantation

## Interventions

- **BIOLOGICAL:** fecal microbiota transplantation

## Key facts

- **NCT ID:** NCT04861649
- **Lead sponsor:** Shanghai Asclepius Meditec Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-09
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861649, "Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04861649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*